Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Tigen Pharma (Sweden) AB
AB
Active
Org 5593325060
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2021
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Tigen Pharma (Sweden) AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MP
Matthias Pannier
Authorized Recipient of Service
Authorized Recipient of Service
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
EG
Emmanuel Georges Savioz
Board of Directors
2022
Former (14)
HJ
Hans Jarl Rutger Arnhult
Deputy Board Member
2021 – 2022
BD
Bo Daniel Falk
Deputy Board Member
2021 – 2022
VE
Viktor Elias Bergman Gullmark
Deputy Board Member
2021 – 2022
EM
Emma Maria Birgitta Wik
Deputy Board Member
2021 – 2022
JH
Jens Hasskarl
Deputy Board Member
2022 – 2025
AM
Anna Matilda Sjödin
Deputy Board Member
2021 – 2022
LA
Lars Anders Larsson
Board of Directors
2021 – 2022
ES
Emelie Sofia Bergh
Deputy Board Member
2021 – 2022
AC
Anna Carolina Maria Bjarnhagen
Deputy Board Member
2021 – 2022
RS
Rolf Stefan Janse
Deputy Board Member
2021 – 2022
MS
Mari Sinikka Kovaniemi Feldt
Deputy Board Member
2021 – 2022
OK
Olina Kristina Maria Wåhlstedt
Deputy Board Member
2021 – 2022
ES
Elin Sofia Gyllenqvist
Deputy Board Member
2021 – 2022
DL
Dorothea Ledergerber
Deputy Board Member
2022 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Tigen Pharma (Sweden) AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network